Canopy Growth Corporation Common Shares (CGC) Valuation
Historical valuation analysis based on 1280 data points (2021-09-13 to 2026-10-16)
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of dist...
Canopy Growth Corporation Common Shares (CGC) currently trades at a P/S ratio of 1.08 (range: 0.23–10.99, 55th percentile — near its historical average).
Canopy Growth Corporation Common Shares trades above its historical valuation range, with most metrics above their median levels.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|---|---|---|---|
| P/S Ratio | 1.08 | 1.04 | 55th | near its historical average |
Canopy Growth Corporation Common Shares (CGC) Valuation & P/E History
Canopy Growth Corporation Common Shares (CGC) is a US-listed stock operating in the Healthcare sector, specifically the Medicinal Chemicals & Botanical Products industry currently trading at $0.72 with a market capitalization of $0.3 billion. This page provides historical valuation analysis for CGC based on 1280 data points covering 2021-09-13 to 2026-10-16.. The P/S ratio of 1.08 compares to a median of 1.04.
CGC Valuation Metrics & Historical Range
The valuation table above shows Canopy Growth Corporation Common Shares's current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether CGC is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests CGC is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for Canopy Growth Corporation Common Shares.
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is CGC Overvalued or Undervalued?
Canopy Growth Corporation Common Shares trades above its historical valuation range, with most metrics above their median levels. The overall valuation percentile of 55 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive CGC is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full CGC analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.CGC trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.